Therapeutic Plasma Exchange for Lupus (SLE)

ASFA guidelines (most recent edition: 2023) classify TPE for severe lupus indications including diffuse alveolar hemorrhage, neuropsychiatric SLE, and catastrophic antiphospholipid syndrome as Category I — meaning plasma exchange is accepted as first-line therapy, either as primary treatment or alongside other modalities. For lupus nephritis specifically, TPE is Category III — meaning the optimal role of plasma exchange is not established and decisions should be individualized.

Beyond ASFA's formal indications, multiple case series have documented use of TPE in refractory cutaneous lupus, severe serositis, and lupus-driven hematologic disease, particularly when conventional immunosuppression has failed or is contraindicated.

We do not present TPE as a replacement for hydroxychloroquine or for the immunosuppressive regimen prescribed by your rheumatologist. We do offer it as a meaningful adjunctive tool in the integrative management of antibody-mediated lupus disease, with full informed consent.

Outpatient TPE at Purety Clinic is intended for stable antibody-burdened lupus patients seeking to lower circulating autoantibody load alongside their existing rheumatologic care. A typical schedule is a 5-session induction course delivered weekly or every other week, followed by reassessment with your rheumatologist and (for responders) a monthly to every-other-month maintenance cadence calibrated to antibody trends and clinical response.

Acute lupus crises — including diffuse alveolar hemorrhage, severe neuropsychiatric SLE, catastrophic antiphospholipid syndrome, or rapidly progressive lupus nephritis — are medical emergencies that belong in a hospital setting under rheumatology, nephrology, and inpatient apheresis teams. We will refer patients in active crisis directly to emergency care; we do not provide outpatient TPE as a substitute for inpatient management of Category I emergency presentations.

Concurrent immunosuppressive medications prescribed by your rheumatologist are continued throughout the outpatient TPE course unless your rheumatologist directs otherwise. We coordinate the timing of rituximab, cyclophosphamide, or IVIG infusions around TPE sessions to avoid clearing those medications from circulation shortly after dosing.